Why did VIVE stock jump pre-market on 13 Mar 2026?

The jump in VIVE stock to **$0.0002** was driven by very low liquidity and small trade sizes, producing a **19,900.00%** one-day change. No major company announcement accompanied the move before the earnings date.

What is Meyka AI’s grade for VIVE stock and what it means?

Meyka AI rates VIVE with a score of **65.09** out of 100, Grade B, suggestion HOLD. The grade weighs benchmark comparisons, sector metrics, growth, and forecasts. It is informational only.

What price targets and forecast exist for VIVE stock?

Meyka AI's model projects **$126.5983** yearly, a theoretical extreme. Practical scenarios include a base target **$0.001** (≈**400%** upside) and a bull target **$0.05** (≈**24,900%** upside). Forecasts are not guarantees.

How risky is trading VIVE stock right now?

Trading VIVE stock is high risk due to micro market cap **$2,145.00**, tiny daily volume **581**, and negative EPS **-1.33**. Price swings can be extreme on small trades.

US Stocks

VIVE (Viveve Medical) NASDAQ pre-market up 19,900% on 13 Mar 2026: top gainer insight

ByHuzaifa Zahoor March 13, 2026March 13, 2026

VIVE stock leads pre-market movers on the NASDAQ on 13 Mar 2026 after a sharp price move to $0.0002, a 19,900.00% one-day change on minimal volume. The move comes on extremely low liquidity with 581 shares traded versus an average 1,883 shares. We outline why the spike matters, the company’s fundamentals, and what traders should watch before the upcoming earnings announcement on 2026-03-20. This preview uses Meyka AI real-time tools and market context for VIVE stock.